N Trademark

Trademark Overview

On Friday, September 6, 2024, a trademark application was filed for N with the United States Patent and Trademark Office. The USPTO has given the N trademark a serial number of 98978253. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, June 10, 2026. This trademark is owned by Nurix Therapeutics, Inc.. The N trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields

General Information

Serial Number98978253
Word MarkN
Filing DateFriday, September 6, 2024
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, June 10, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 15, 2025

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Pseudo MarkNURIX
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields
Description of MarkThe mark consists of a stylized letter N in an intersecting square design.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 6, 2024
Primary Code042
First Use Anywhere DateMonday, January 13, 2025
First Use In Commerce DateMonday, January 13, 2025

Trademark Owner History

Party NameNurix Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005
US
Party NameNurix Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94158
US

Trademark Events

Event DateEvent Description
Friday, September 6, 2024NEW APPLICATION ENTERED
Saturday, March 15, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 15, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, March 17, 2025ASSIGNED TO EXAMINER
Wednesday, March 19, 2025EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 19, 2025EXAMINERS AMENDMENT E-MAILED
Wednesday, March 19, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 19, 2025EXAMINER'S AMENDMENT ENTERED
Thursday, March 20, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 9, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 15, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 15, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 10, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 20, 2025SOU TEAS EXTENSION RECEIVED
Thursday, November 20, 2025SOU EXTENSION 1 FILED
Friday, November 21, 2025SOU EXTENSION 1 GRANTED
Friday, November 21, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 25, 2025TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, November 25, 2025TEAS STATEMENT OF USE RECEIVED
Wednesday, April 22, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 27, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 9, 2026SOU TEAS EXTENSION RECEIVED
Monday, May 12, 2025DIVISIONAL REQUEST RECEIVED
Wednesday, June 10, 2026DIVISIONAL PROCESSING COMPLETE

Related Keywords

fields biotechnology pharmaceutical development research